-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Overweight on NICE, Lowers Price Target to $193

Benzinga·08/15/2025 12:46:53
Listen to the news
Morgan Stanley analyst Hamza Fodderwala maintains NICE (NASDAQ:NICE) with a Overweight and lowers the price target from $202 to $193.